T cell targeting in cancer therapy [PDF]
, 1991 Bolhuis, R.L.H. (Reinder) +2 more
core +1 more source
Research trends of cellular immunotherapy for primary liver cancer: A bibliometric analysis. [PDF]
Hum Vaccin ImmunotherWu X, Jin B, Liu X, Mao Y, Wan X, Du S.
europepmc +1 more source
Characterization of cytotoxic cells from reovirus-infected SCID mice: activated cells express natural killer- and lymphokine-activated killer-like activity but fail to clear infection [PDF]
, 1995 J Taterka, John J. Cebra, D H Rubin
openalex +1 more source
Reinforced Cytotoxicity of Lymphokine‐activated Killer Cells toward Glioma Cells by Transfection of the Killer Cells with the γ‐Interferon Gene [PDF]
, 1995 Masaaki Mizuno +3 more
openalex +1 more source
Usefulness of Lymphokine‐activated Killer Cells Generated from Bone Marrow Mononuclear Cells for the Purging of Residual Tumor Cells in Peripheral Blood Stem Cell Graft [PDF]
, 1996 Fumio Komatsu, Michiko Kajiwara
openalex +1 more source
Therapeutic potential of adenosine receptor modulators in cancer treatment. [PDF]
RSC AdvMaity P, Ganguly S, Deb PK.
europepmc +1 more source
A study on lymphokine activated killer(LAK) cell activity in inflammatory bowel disease(IBD).
, 1990 Yohei Mizuta
openalex +2 more sources
Current status of cytokine-induced killer cells and combination regimens in breast cancer. [PDF]
Front ImmunolJiang Y, Qiu J, Ye N, Xu Y.
europepmc +1 more source
Induction of lymphokine activated killer cells in serum-free medium.
, 1991 Ryouji Tani +3 more
openalex +2 more sources